
Chinese General Practice ›› 2019, Vol. 22 ›› Issue (31): 3850-3856.DOI: 10.12114/j.issn.1007-9572.2019.00.589
Special Issue: 高血压最新文章合辑
• Monographic Research • Previous Articles Next Articles
Published:2019-11-05
Online:2019-11-05
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2019.00.589
| [1]KEARNEY P M,WHELTON M,REYNOLDS K,et al.Global burden of hypertension:analysis of worldwide data[J].Lancet,2005,365(9455):217-223.DOI:10.1016/s0140-6736(05)17741-1. [2]MILLS K T,BUNDY J D,KELLY T N,et al.Global disparities of hypertension prevalence and control:a systematic analysis of population-based studies from 90 countries[J].Circulation,2016,134(6):441-450.DOI:10.1161/circulationaha.115.018912. [3]胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.DOI:10.3969/j.issn.1000-3614.2019.03.001. HU S S,GAO R L,LIU L S,et al.Summary of the 2018 report on cardiovascular diseases in China[J].Chinese Circulation Journal,2019,34(3):209-220.DOI:10.3969/j.issn.1000-3614.2019.03.001. [4]DORES H,SANTOS P,SALVADOR F,et al.Blood pressure in young adults[J].Rev Port Cardiol,2010,29(10):1495-1508.DOI:10.1016/S0300-8932(10)70260-8. [5]全国血压抽样调查协作组.中国高血压的患病率、知晓率及治疗和控制状况:1991年抽样调查结果[J].高血压杂志,1995,3(s1):16-20. National Blood Pressure Sampling Survey Collaborative Group.Hypertension prevalence and the status of people awareness,treatment,and control in China:a national-wide survey in 1991[J].Chinese Journal of Hypertension,1995,3(s1):16-20. [6]李立明,饶克勤,孔灵芝,等.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7):478-484.DOI:10.3760/j.issn:0254-6450.2005.07.004. LI L M,RAO K Q,KONG L Z,et al.A description on the Chinese national nutrition and health survey in 2002[J].Chinese Journal of Epidemiology,2005,26(7):478-484.DOI:10.3760/j.issn:0254-6450.2005.07.004. [7]CHOBANIAN A V,BAKRIS G L,BLACK H R,et al.Seventh report of the Joint National Committee on Prevention,Detection,Evaluation,and Treatment of High Blood Pressure[J].Hypertension,2003,42(6):1206-1252.DOI:10.1161/01.HYP.0000107251.49515.c2. [8]中国高血压防治指南修订委员会,高血压联盟中华医学会心血管病学分会,中国医师协会高血压专业委员会,等.中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56.DOI:10.3969/j.issn.1007-5410.2019.01.002. Writing Group of 2018 Chinese Guidelines for the Management of Hypertension,Hypertension Alliance of Chinese Medical Association Cardiovascular Disease Branch,Chinese Medical Association Hypertension Professional Committee,et al.Chinese guidelines for the prevention and treatment of hypertension(2018)[J].Chin J Cardiovasc,2019,24(1):24-56.DOI:10.3969/j.issn.1007-5410.2019.01.002. [9]青年[EB/OL].[2018-11-12].http://baike.baidu.com.item/%E9%9D%92%E5%B9%B41/398408. [10]EPSTEIN L J,KRISTO D,STROLLO P J JR,et al.Clinical guideline for the evaluation,management and long-term care of obstructive sleep apnea in adults[J].J Clin Sleep Med,2009,5(3):263-276. [11]中国医师协会睡眠医学专业委员会.成人阻塞性睡眠呼吸暂停多学科诊疗指南[J].中华医学杂志,2018,98(24):1902-1914.DOI:10.3760/cma.j.issn.0376-2491.2018.24.003.http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyx201824003. [12]中国医疗保健国际交流促进会血管疾病高血压分会专家共识起草组.肾动脉狭窄的诊断和处理中国专家共识[J].中国循环杂志,2017,32(9):835-844.DOI:10.3969/j.issn.1000-3614.2017.09.002.http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgxhzz201709002. [13]中华医学会风湿病学分会.大动脉炎诊断及治疗指南[J].中华风湿病学杂志,2011,15(2):119-120.DOI:10.3760/cma.j.issn.1007-7480.2011.02.013.http://www.doc88.com/p-0071982146143.html. [14]PERSU A,GIAVARINI A,TOUZE E,et al.European consensus on the diagnosis and management of fibromuscular dysplasia[J].J Hypertens,2014,32(7):1367-1378.DOI:10.1097/hjh.0000000000000213. [15]中华医学会内分泌学分会肾上腺学组.原发性醛固酮增多症诊断治疗的专家共识[J].中华内分泌代谢杂志,2016,32(3):188-195.DOI:10.3760/cma.j.issn.1000-6699.2016.03.003.http://d.old.wanfangdata.com.cn/Periodical/zhnfmdx201603003. [16]SONG Y,YANG S,HE W,et al.Confirmatory tests for the diagnosis of primary aldosteronism:a prospective diagnostic accuracy study[J].Hypertension,2018,71(1):118-124.DOI:10.1161/hypertensionaha.117.10197. [17]中华医学会妇产科学分会内分泌学组及指南专家组.多囊卵巢综合征中国诊疗指南[J].中华妇产科杂志,2018,53(1):2-6.DOI:10.3760/cma.j.issn.0529-567x.2018.01.002.http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhfck201801002. [18]中华医学会内分泌学分会肾上腺学组.嗜铬细胞瘤和副神经节瘤诊断治疗的专家共识[J].中华内分泌代谢杂志,2016,32(3):181-187.DOI:10.3760/cma.j.issn.1000-6699.2016.03.002.http://d.old.wanfangdata.com.cn/Periodical/zhnfmdx201603002. [19]中国垂体腺瘤协作组.中国库欣病诊治专家共识(2015)[J].中华医学杂志,2016,96(11):835-840.DOI:10.3760/cma.j.issn.0376-2491.2016.11.002.http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_zhyx201611002. [20]WILLIAMS B,MANCIA G,SPIERING W,et al.2018 ESC/ESH guidelines for the management of arterial hypertension[J].Eur Heart J,2018,39(33):3021-3104.DOI:10.1093/eurheartj/ehy339. [21]王志华,初少莉,陈绍行,等.高血压住院患者病因及危险因素分析[J].高血压杂志,2005,13(8):504-509.DOI:10.3969/j.issn.1673-7245.2005.08.017. WANG Z H,CHU S L,CHEN S X,et al.Analysis of etiology and risk factors of in-patients with hypertension[J].Chin J Hypertension,2005,13(8):504-509.DOI:10.3969/j.issn.1673-7245.2005.08.017. [22]DANIELSON M,DAMMSTROM B.The prevalence of secondary and curable hypertension[J].Acta Med Scand,1981,209(6):451-455.DOI:10.1111/j.0954-6820.1981.tb11628.x. [23]ANDERSON G H JR,BLAKEMAN N,STREETEN D H.The effect of age on prevalence of secondary forms of hypertension in 4 429 consecutively referred patients[J].J Hypertens,1994,12(5):609-615. [24]OMURA M,SAITO J,YAMAGUCHI K,et al.Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan[J].Hypertens Research,2004,27(3):193-202. [25]FLORCZAK E,PREJBISZ A,SZWENCH-PIETRASZ E,et al.Clinical characteristics of patients with resistant hypertension:the RESIST-POL study[J].J Hum Hypertens,2013,27(11):678-685.DOI:10.1038/jhh.2013.32. [26]WANG L,LI N,YAO X,et al.Detection of secondary causes and coexisting diseases in hypertensive patients:OSA and PA are the common causes associated with hypertension[J].Biomed Res Int,2017(6):1-8.DOI:10.1155/2017/8295010. [27]CHARLES L,TRISCOTT J,DOBBS B.Secondary hypertension:discovering the underlying cause[J].Am Fam Physician,2017,96(7):453-461. [28]NOILHAN C,BARIGOU M,BIELER L,et al.Causes of secondary hypertension in the young population:a monocentric study[J].Ann Cardiol Angeiol(Paris),2016,65(3):159-164.DOI:10.1016/j.ancard.2016.04.016. [29]RUDNICK K V,SACKETT D L,HIRST S,et al.Hypertension in a family practice[J].Can Med Assoc J,1977,117(5):492-497.DOI:10.1016/0091-7435(79)90041-0. [30]STREETEN D H,ANDERSON G H,ELIAS M F.Prevalence of secondary hypertension and unusual aspects of the treatment of hypertension in elderly individuals[J].Geriatr Nephrol Urol,1992,2(2):91-98.DOI:10.1007/BF00451671. [31]ARAR M Y,HOGG R J,ARANT B S JR,et al.Etiology of sustained hypertension in children in the southwestern United States[J].Pediatr Nephrol,1994,8(2):186-189.DOI:10.1007/BF00865475. [32]HAAS D C,FOSTER G L,NIETO F J,et al.Age-dependent associations between sleep-disordered breathing and hypertension:importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the sleep heart health study[J].Circulation,2005,111(5):614-621.DOI:10.1161/01.cir.0000154540.62381.cf. [33]CHAHAL C A,SOMERS V K.Secondary hypertension:obstructive sleep apnea[J].J Am Soc Hypertens,2015,9(3):244-247.DOI:10.1016/j.jash.2015.02.001. [34]PEPPARD P E,YOUNG T,PALTA M,et al.Prospective study of the association between sleep-disordered breathing and hypertension[J].N Engl J Med,2000,342(19):1378-1384.DOI:10.1056/nejm200005113421901. [35]MARIN J M,AGUSTI A,VILLAR I,et al.Association between treated and untreated obstructive sleep apnea and risk of hypertension[J].JAMA,2012,307(20):2169-2176.DOI:10.1001/jama.2012.3418. [36]LANTELME P,HARBAOUI B,COURAND P Y.Renal artery stenosis[J].Rev Prat,2015,65(6):822-826. [37]PENG M,JIANG X J,DONG H,et al.Etiology of renal artery stenosis in 2 047 patients:a single-center retrospective analysis during a 15-year period in China[J].J Hum Hypertens,2016,30(2):124-128.DOI:10.1038/jhh.2015.40. [38]CONN J W.Primary aldosteronism[J].J Lab Clin Med,1955,45(4):661-664. [39]PIADITIS G,MARKOU A,PAPANASTASIOU L,et al.Progress in aldosteronism:a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension[J].Eur J Endocrinol,2015,172(5):R191-203.DOI:10.1530/eje-14-0537. [40]FUNDER J W,CAREY R M,MANTERO F,et al.The management of primary aldosteronism:case detection,diagnosis,and treatment:an endocrine society clinical practice guideline[J].J Clin Endocrinol Metab,2016,101(5):1889-1916.DOI:10.1210/jc.2015-4061. [41]MILLIEZ P,GIRERD X,PLOUIN P F,et al.Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism[J].J Am Coll Cardiol,2005,45(8):1243-1248.DOI:10.1016/j.jacc.2005.01.015. [42]FOURKIOTIS V,VONEND O,DIEDERICH S,et al.Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism[J].Eur J Endocrinol,2013,168(1):75-81.DOI:10.1530/eje-12-0631. [43]SUNDSTROM J,NEOVIUS M,TYNELIUS P,et al.Association of blood pressure in late adolescence with subsequent mortality:cohort study of Swedish male conscripts[J].BMJ,2011,342:d643.DOI:10.1136/bmj.d643. [44]VIERA A J,ZHU S,HINDERLITER A L,et al.Diurnal blood pressure pattern and development of prehypertension or hypertension in young adults:the CARDIA study[J].J Am Soc Hypertens,2011,5(1):48-55.DOI:10.1016/j.jash.2010.12.002. [45]ZHANG Y,MORAN A E.Trends in the prevalence,awareness,treatment,and control of hypertension among young adults in the United States,1999 to 2014[J].Hypertension,2017,70(4):736-742.DOI:10.1161/hypertensionaha.117.09801. [46]陈诗颖,吴逸海,林少炜,等.福建省沿海地区城镇青年高血压流行现状及其影响因素[J].中华高血压杂志,2015,23(11):1080-1083.DOI:10.16439/j.cnki.1673-7245.2015.11.029. CHEN S Y,WU Y H,LIN S W,et al.Prevalence of hypertension among urban youth in coastal areas of Fujian Province and its influencing factors[J].Chinese Journal of Hypertension,2015,23(11):1080-1083.DOI:10.16439/j.cnki.1673-7245.2015.11.029. |
| [1] | ZHOU Xiaoya, WANG Weikai, LIU Qian, LI Jianhua, SUN Bo, WANG Yanxia. Study of the Interaction between Sleep Quality and Melatonin Receptor 1B Gene Polymorphism on Gestational Hypertension [J]. Chinese General Practice, 2026, 29(21): 2975-2981. |
| [2] | REYILAI· Maimaiti, ZHOU Yiran, WU Yun, LIU Zhencheng, LU Yaoqin, WU Haiyan. Association between Novel Obesity Indicators and Cardiovascular Disease Risk in Hypertensive Patients [J]. Chinese General Practice, 2026, 29(20): 2836-2845. |
| [3] | ZHANG Xiaojuan, LIU Yang, PENG Bo, YE Yuan, ZHU Kun. Study on the Prevention and Treatment of Hypertension and Diabetes Mellitus in Community Hospital [J]. Chinese General Practice, 2026, 29(19): 2614-2620. |
| [4] | ZHAO Huili, LU Lina, ZHUO Ya, WANG Xin. Clinical Characteristics and Risk Factors for Recurrence of Cryptogenic Organizing Pneumonia [J]. Chinese General Practice, 2026, 29(19): 2648-2655. |
| [5] | MIAO Jingjie, ZHANG Jinwen, WU Qianhao, HAN Peipei. Research Advances on the Effects of Intermittent Fasting on Cardiometabolic Diseases [J]. Chinese General Practice, 2026, 29(18): 2538-2545. |
| [6] | XU Ping, MA Yan, HUANG Li, HE Meiliang, HOU Yunfeng, WANG Dewang, SUN Panpan, LIU Zheng, GUO Yanfang, XU Ying. Association between Weight-adjusted Waist Index and Comorbidity of Hypertension, Diabetes and Dyslipidemia in Community-dwelling Adults [J]. Chinese General Practice, 2026, 29(16): 2198-2204. |
| [7] | QIU Xinyu, ZHAO Qian, CHEN Yufei, JIAMULE· Maimaitiyiming, HAN Congcong, AIKEDAN· Aierken, LI Xiaomei, YANG Yining. Weight Status and Metabolic Characteristics on the Longitudinal Trajectory of Systolic Blood Pressure: a Cohort Study [J]. Chinese General Practice, 2026, 29(15): 2006-2013. |
| [8] | LIU Fan, CHEN Qiuyu, LI Jing. Development and Validation of a Nighttime Hypertension Screening Model for Subclinical High-risk Populations: a Single-center Cohort Study [J]. Chinese General Practice, 2026, 29(15): 1998-2005. |
| [9] | LIU Tianyuan, SANG Wanyue, PENG Jiping, CHENG Siyi, HUANG Yiyi, LI Ouwen, JIANG Hong, ZHOU Xiaoya. Correlation Analysis between Neurofilament Light Chain and the Risk of Left Ventricular Hypertrophy in Patients with Nocturnal Hypertension [J]. Chinese General Practice, 2026, 29(15): 2014-2021. |
| [10] | WANG Siman, ZHANG Mengchu, LI Wen, XU Ai, XU Jin, GUO Rui, YAN Haixia. Research on the Construction of a Risk Prediction Model for Primary Hypertension with Left Ventricular Hypertrophy Based on TCM Syndromes and Pulse Graph Parameters [J]. Chinese General Practice, 2026, 29(14): 1840-1848. |
| [11] | WU Chunxiang, TIAN Jie, GUO Yi, DENG Bo, YU Jie, CAI Ning, SHEN Li. Analysis of the 8-year Trajectories and Influencing Factors of Medical-help-seeking Behavior of Hypertensive Patients [J]. Chinese General Practice, 2026, 29(13): 1660-1665. |
| [12] | SONG Lu, WANG Liye, XIU Chunxia, FENG Baojing, FENG Liping, GAO Yansong, LI Meng, DAI Yan. The Correlation Study of Pulmonary Function and Blood Pressure Variability in Patients with Chronic Obstructive Pulmonary Disease and Hypertension [J]. Chinese General Practice, 2026, 29(10): 1311-1315. |
| [13] | JIAO Xitong, LIU Lu, GUO Jiayue, YOU Lili. Prospects for the Application of Digital Therapy Products for Hypertension at Home and Abroad and the Implications for China [J]. Chinese General Practice, 2026, 29(10): 1354-1360. |
| [14] | ZHANG Qiuyu, HU Xiaoyong, TANG Rui, LI Hongjian. Correlation between Chinese Visceral Adiposity Index and Nocturnal Hypertension in Young and Middle-aged People [J]. Chinese General Practice, 2026, 29(07): 872-878. |
| [15] | LI Jie, YANG Xinhui, CAO Li, ZHANG Jing, JIANG Yue. Case Analysis of General Practice Diagnosis and Treatment in a "Three High" Patient with Coexistence and Fatty Liver Disease [J]. Chinese General Practice, 2026, 29(06): 810-816. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||